Uber Drives Dual MDL Challenges to Ninth Circuit -
Key Takeaways -
Ninth Circuit review of Uber’s non-consolidation clauses in an MDL context could generate new precedent on the enforceability of similar clauses and shape...more
11/1/2024
/ Amended Complaints ,
Jurisdiction ,
Litigation Funding ,
Litigation Strategies ,
Multidistrict Litigation ,
Popular ,
Public Safety ,
Royal Canin USA Inc v Wullschleger ,
SCOTUS ,
Sexual Assault ,
Terms of Use ,
Third-Party ,
Tort ,
Uber
U.S. Environmental Protection Agency (“EPA”) has designated PFOA and PFOS as "Hazardous Substances" under CERCLA, marking the agency's first use of Section 102(a) authority and signaling potential widespread industry impact...more
4/29/2024
/ CERCLA ,
Contamination ,
Drinking Water ,
Environmental Policies ,
Environmental Protection Agency (EPA) ,
Hazardous Substances ,
Landfills ,
PFAS ,
Public Health ,
Regulatory Agenda ,
Reporting Requirements ,
Site Remediation
EPA Strengthens Focus on PFAS -
Late last month, U.S. EPA finalized a rule requiring current and historical manufacturers and importers of perfluoroalkyl substances (PFAS) and PFAS-containing materials to report on PFAS...more
10/25/2023
/ CERCLA ,
Compliance ,
Enforcement ,
Environmental Protection Agency (EPA) ,
Final Rules ,
Hazardous Substances ,
New Regulations ,
PFAS ,
Popular ,
RCRA ,
Safe Drinking Water Act
EPA has announced proposed national drinking water standards for six PFAS compounds, including PFOA and PFOS.
The regulation would create enforceable Maximum Contaminant Levels for these PFAS, and states would be required...more
3/20/2023
/ CERCLA ,
Compliance ,
Contamination ,
Drinking Water ,
Environmental Policies ,
Environmental Protection Agency (EPA) ,
PFAS ,
Proposed Regulation ,
Public Health ,
Risk Mitigation ,
Toxic Chemicals
The U.S. Environmental Protection Agency (EPA) announced new interim lifetime drinking water health advisories for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), as well as final health advisories for...more
6/16/2022
/ Biden Administration ,
Contamination ,
Discharge of Pollutants ,
Drinking Water ,
Enforcement Guidance ,
Environmental Policies ,
Environmental Protection Agency (EPA) ,
Hazardous Substances ,
Infrastructure ,
New Guidance ,
PFAS ,
Public Health ,
Regulatory Agenda ,
Toxic Chemicals ,
Toxic Exposure
After two years of consideration, the FDA has restricted the sale of breast implants to healthcare providers that use an FDA-approved patient-decision checklist to discuss the benefits and risks of the implants with patients....more
Key Takeaways Likened by some to motherhood and apple pie, the Environmental Rights Amendment was adopted by New York with a resounding “Yes” on November 2, 2021, with approximately 68% of voters approving the new amendment....more
Key Takeaways - The COVID-19 pandemic led the U.S. Food and Drug Administration (FDA) to pause most foreign and domestic inspections and begin conducting remote interactive evaluations. FDA has since issued a written policy...more
Key Takeaways - The PFAS litigation landscape – already involving PFAS manufacturers and purchasers of PFAS-containing fluoropolymers and firefighting films – is in the process of expanding, which is putting new companies and...more